• Pharma Regulatory Services in Czech Republic

    Overview

    Market for drugs and biological products in Czech Republic is catching up with global demand. Prior to marketing their products in market, the pharmaceutical product manufacturers must obtain approval from the State Institute for Drug Control of Czech Republic by submitting a Marketing Authorization Application (MAA). As per the Directive 2001/83/EC, any new medicinal product shall be registered through a Marketing Authorization Application (MAA) following certain procedures:  

  • Regulatory Services in Czech Republic

    Overview

    In order to gain access to the Czech Republic, foreign manufacturers are obliged to get authorizations from the State Institute for Drug Control (SUKL). Apart from obtaining must-to-have CE marking for medical devices, manufacturers need an authorized representative for obtaining registrations and gain market approvals. To do so, the challenge lies with procedural complexities that a foreign manufacturer may find difficult to handle.